EMA — authorised 20 November 2006
- Marketing authorisation holder: BRISTOL-MYERS SQUIBB PHARMA EEIG
- Status: approved
🇪🇺 Sprycel in European Union
EMA authorised Sprycel on 20 November 2006
Marketing authorisation
Sprycel in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in European Union
Frequently asked questions
Is Sprycel approved in European Union?
Yes. EMA authorised it on 20 November 2006.
Who is the marketing authorisation holder for Sprycel in European Union?
BRISTOL-MYERS SQUIBB PHARMA EEIG holds the EU marketing authorisation.